198 related articles for article (PubMed ID: 38672540)
1. The Real-Life Impact of Primary Tumor Resection of Synchronous Metastatic Colorectal Cancer-From a Clinical Oncologic Point of View.
Pécsi B; Mangel LC
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672540
[TBL] [Abstract][Full Text] [Related]
2. Primary Tumour Resection Could Improve the Survival of Unresectable Metastatic Colorectal Cancer Patients Receiving Bevacizumab-Containing Chemotherapy.
Wang Z; Liang L; Yu Y; Wang Y; Zhuang R; Chen Y; Cui Y; Zhou Y; Liu T
Cell Physiol Biochem; 2016; 39(3):1239-46. PubMed ID: 27595400
[TBL] [Abstract][Full Text] [Related]
3. The Real-Life Impact of mFOLFIRI-Based Chemotherapies on Elderly Patients-Should We Let It or Leave It?
Pécsi B; Mangel LC
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958320
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution.
Lau JW; Chang HS; Lee KY; Gwee YX; Lee WQ; Chong CS
J Dig Dis; 2018 Sep; 19(9):550-560. PubMed ID: 30117288
[TBL] [Abstract][Full Text] [Related]
5. The effect of primary tumour resection on patients with synchronous metastatic colorectal cancer treated with cetuximab-containing regimens.
Sertesen E; Yekedüz E; Köksoy EB; Ürün Y; Erkek AB; Demirci S; Ünal AE; Utkan G
ANZ J Surg; 2023 Apr; 93(4):945-950. PubMed ID: 36259228
[TBL] [Abstract][Full Text] [Related]
6. Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase 3 CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.
van der Kruijssen DEW; Elias SG; van de Ven PM; van Rooijen KL; Lam-Boer J'; Mol L; Punt CJA; Sommeijer DW; Tanis PJ; Nielsen JD; Yilmaz MK; Van Riel JMGH; Wasowiz-Kemps DK; Loosveld OJL; van der Schelling GP; de Groot JWB; van Westreenen HL; Jakobsen HL; Fromm AL; Hamberg P; Verseveld M; Jaensch C; Liposits GI; van Duijvendijk P; Hadj JO; van der Hoeven JAB; Trajkovic M; de Wilt JHW; Koopman M;
Ann Oncol; 2024 Jun; ():. PubMed ID: 38852675
[TBL] [Abstract][Full Text] [Related]
7. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
[TBL] [Abstract][Full Text] [Related]
8. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy.
Yeom SS; Lee SY; Kwak HD; Kim CH; Kim YJ; Kim HR
Medicine (Baltimore); 2020 Feb; 99(7):e19258. PubMed ID: 32049866
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
[TBL] [Abstract][Full Text] [Related]
10. Primary tumor resection in patients with unresectable colorectal cancer with synchronous metastases could improve the activity of poly-chemotherapy: A trial-level meta-analysis.
Colloca GA; Venturino A; Guarneri D
Surg Oncol; 2022 Sep; 44():101820. PubMed ID: 35932621
[TBL] [Abstract][Full Text] [Related]
11. Primary Tumor Resection and Overall Survival in Patients With Metastatic Colorectal Cancer Treated With Palliative Intent.
Wong SF; Wong HL; Field KM; Kosmider S; Tie J; Wong R; Tacey M; Shapiro J; Nott L; Richardson G; Cooray P; Jones I; Croxford M; Gibbs P
Clin Colorectal Cancer; 2016 Sep; 15(3):e125-32. PubMed ID: 26803709
[TBL] [Abstract][Full Text] [Related]
12. Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies.
Fanotto V; Rossini D; Casagrande M; Bergamo F; Spagnoletti A; Santini D; Antoniotti C; Cupini S; Daniel F; Nasca V; Vetere G; Zaniboni A; Borelli B; Carullo M; Conca V; Passardi A; Tamburini E; Masi G; Pella N; Cremolini C
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001711
[TBL] [Abstract][Full Text] [Related]
13. Primary Tumor Resection Provides Survival Benefits for Patients with Synchronous Brain Metastases from Colorectal Cancer.
Cheng X; Li Y; Chen D; Xu X; Liu F; Zhao F
Diagnostics (Basel); 2022 Jun; 12(7):. PubMed ID: 35885491
[TBL] [Abstract][Full Text] [Related]
14. Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.
van der Kruijssen DEW; Elias SG; Vink GR; van Rooijen KL; 't Lam-Boer J; Mol L; Punt CJA; de Wilt JHW; Koopman M;
JAMA Surg; 2021 Dec; 156(12):1093-1101. PubMed ID: 34613339
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab Can Be an Effective and Low-Toxicity Maintenance Treatment Drug in Patients With Metastatic Colorectal Cancer: A Real-World Study of Zhejiang Cancer Hospital.
Yuan M; Wang Z; Zhao Y; Feng T; Lv W; Zhong H
Front Pharmacol; 2021; 12():632076. PubMed ID: 34122063
[TBL] [Abstract][Full Text] [Related]
16. Influence of primary tumor location and resection on survival in metastatic colorectal cancer.
Tharin Z; Blanc J; Alaoui IC; Bertaut A; Ghiringhelli F
World J Gastrointest Oncol; 2020 Nov; 12(11):1296-1310. PubMed ID: 33250962
[TBL] [Abstract][Full Text] [Related]
17. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
Russo A; DiPeri T; Dumitra T; Tseng J; Pletcher E; Justo M; Chen C; Nissen N; Amersi F; Gong J; Hendifar A; Gangi A
J Neuroendocrinol; 2024 May; ():e13399. PubMed ID: 38760997
[TBL] [Abstract][Full Text] [Related]
18. Does primary tumor resection contribute to overall survival in unresectable synchronous metastatic colorectal cancer?
Ergun Y; Bal O; Dogan M; Ucar G; Dirikoc M; Acikgoz Y; Bacaksiz F; Uncu D
J Res Med Sci; 2020; 25():14. PubMed ID: 32174986
[TBL] [Abstract][Full Text] [Related]
19. Is primary tumor resection associated with a longer survival in colon cancer and unresectable synchronous metastases? A 4-year multicentre experience.
de Mestier L; Neuzillet C; Pozet A; Desot E; Deguelte-Lardière S; Volet J; Karoui M; Kianmanesh R; Bonnetain F; Bouché O
Eur J Surg Oncol; 2014 Jun; 40(6):685-91. PubMed ID: 24630774
[TBL] [Abstract][Full Text] [Related]
20. Impact of Upfront Chemotherapy on the Effect of Primary Tumour Resection for Asymptomatic Synchronous Colorectal Cancer With Unresectable Metastases: A Propensity-Score-Matched Cohort Analysis.
Huang L; Wei G; Chen N; Liu J; Wang Z; Yu Y; Qiu M
Clin Med Insights Oncol; 2022; 16():11795549221085054. PubMed ID: 35355515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
